BB Biotech 2nd Line Ord Shs (BBZA) Aandeelprys en nuus

TuisBBZA • FRA

BB Biotech 2nd Line Ord Shs

€40,35

29 Nov., 22:59:48 GMT+1 · EUR · FRA · Vrywaring

AandeelDE-gelyste effekHoofkantoor in CH

Vorige sluiting

€39,80

Dagwisseling

€39,30 - €40,45

Jaarwisseling

€37,60 - €52,60

Markkapitalisasie

2,05 mjd CHF

Gemiddelde volume

3,31 k

P/V-verhouding

Dividend-opbrengs

Primêre beurs

SWX

Marknuus

TheStreet

12 uur gelede

The Trump Trade rally has stocks at record highs. Where do we go from here?

Diversifying Beyond The Vanilla S&P 500: Two ETFs To Watch In 2025

The Stock Market Just Breached a Never-Before-Seen Threshold -- and History Couldn't Be Clearer About What Happens Next

The Stock Market Is Headed for Another Big Gain. Where Is the S&P 500 Headed Next, According to History?

The simple 4-part filter that a legacy fund has used to beat the S&P 500 for over 2 decades

Will Palantir Technologies' Move to the Nasdaq Help the Stock Climb Even Higher?

Meer oor

BB Biotech AG is a Swiss investment company in the field of biotechnology. The company invests mainly in the United States and Western Europe and is managed by Bellevue Asset Management, a division of Bellevue Group, which is listed on the Swiss Stock Exchange. It is one of the largest investment companies in the biotech sector. Wikipedia

Gestig

09 Nov. 1993

Hoofkwartier

Küsnacht, Zurich
Switserland

Webwerf

bbbiotech.ch